The pathogenetic role of the AR pathway is evident in the majority of prostate cancer cases, both androgen-dependent and castration-resistant, as indicated by the continuously increasing levels of the prostate-specific antigen (PSA). The gene discussed is PROS1; the disease is prostate carcinoma.